SCHEMBL13086349

SCHEMBL13086349

CCCCCCN(CCCCCC)c1ccc(/C=C/c2ccc(C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
INSR P06213 2/20 0.49
CHRM2 P08172 1/20 0.49
CHRM4 P08173 1/20 0.49
CHRM5 P08912 1/20 0.49
CHRM1 P11229 1/20 0.49
CHRM3 P20309 1/20 0.49
KDM4A O75164 4/20 0.48
KDM2A Q9Y2K7 4/20 0.48
CNR2 P34972 1/20 0.45
KCNH2 Q12809 3/20 0.42
MCHR1 Q99705 1/20 0.42
ATG4B Q9Y4P1 1/20 0.40
NFE2L2 Q16236 1/20 0.40
ALOX5 P09917 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18159314 0.93 CHRM2 (0.55) INSRCHRM2CHRM4CHRM5CHRM1
SCHEMBL18159320 0.93 CHRM2 (0.55) INSRCHRM2CHRM4CHRM5CHRM1
SCHEMBL7719119 0.93 CHRM2 (0.54) INSRCHRM2CHRM4CHRM5CHRM1
SCHEMBL1832514 0.91 CHRM2 (0.55) INSRCHRM2CHRM4CHRM5CHRM1
SCHEMBL5712573 0.91 CHRM2 (0.55) INSRCHRM2CHRM4CHRM5CHRM1
SCHEMBL5712574 0.91 CHRM2 (0.55) INSRCHRM2CHRM4CHRM5CHRM1
SCHEMBL2604957 0.90 CHRM2 (0.57) INSRCHRM2CHRM4CHRM5CHRM1
SCHEMBL22321039 0.89 CNR2 (0.51) CNR2KCNH2MCHR1NPC1RAB9A
SCHEMBL22321046 0.89 CNR2 (0.51) CNR2KCNH2MCHR1NPC1RAB9A
SCHEMBL22321066 0.89 CNR2 (0.51) CNR2KCNH2MCHR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100266507-A1 LUMINESCENT COMPOUNDS SETA BIOMEDICALS, LLC 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100266507-A1 LUMINESCENT COMPOUNDS SQLE, COASY, ZKSCAN2 INSR 1817/4885CHRM2 3531/4885CHRM4 2847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.